Gland Pharma Ltd - 543245 - Reply For The Clarification Sought On News Item Appearing In "Media / Publication"
Reply for the clarification sought on news item appearing in "Media / Publication"29-11-2022
29-11-2022
Gland Pharma Ltd - 543245 - Reply For The Clarification Sought On News Item Appearing In "Media / Publication"
Reply for the clarification sought on news item appearing in "Media / Publication"29-11-2022
Gland Pharma Ltd - 543245 - Clarification sought from Gland Pharma Ltd
The Exchange has sought clarification from Gland Pharma Ltd on November 29, 2022, with reference to news appeared onhttps://www.livemint.com dated November 29, 2022 quoting "Gland Pharma''s Chinese owner mulls sale of drugmaker, shares jump"The reply is awaited.29-11-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of 1,800 Equity shares under ESOP24-11-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor Meeting24-11-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor Meeting21-11-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor Meetings14-11-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor Meetings10-11-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor Meeting09-11-2022
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor meetings07-11-2022